InsidersTradesSigma
Browse the complete record of transactions filed by Kutok Jeffery, Directeur Scientifique. Director active across 1 companies, notably Epizyme, Inc.. Aggregated, 5 reports have been published. Total volume traded: €8k. The latest transaction was filed on 11 April 2022 (Cession). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Jeffery Kutok is the Chief Scientific Officer at Epizyme, Inc. He oversees the company's research and development initiatives, ensuring innovation in treatment areas. His scientific expertise is crucial for Epizyme's success.